Potential contribution of haemoconcentration to changes in lipid variables with empagliflozin in patients with type 2 diabetes: A post hoc analysis of pooled data from four phase 3 randomized clinical trials.

Diabetes Obes Metab · 2021 · PMC9290508 · PMID 34463415

Europe PMC DOI

hedged sentence

—

closest p

—

boldest claim

The sentences

did not reach statistical significanceno p-value reported

A similar pattern was observed between serum albumin and triglycerides, but the association between the changes (increases) in triglycerides associated with changes (increases) in serum albumin did not reach statistical significance with either empagliflozin dose (Figure 1C ; Table S1 ).

also in 111,027 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.